Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: February 10, 2026
Reporting Period: Event date February 10, 2026
Business Context: The Company is a Delaware corporation listed on the Nasdaq Capital Market. This filing serves as a Regulation FD disclosure regarding the release of presentation materials intended for use in management presentations about the Company's operations and performance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the availability of presentation materials and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial position or operations are reported within this specific filing. The only reported event is the posting of "Presentation Materials" to the Company's website on February 10, 2026.
Guidance, Outlook, and Risks
- Management Commentary: Management intends to use the attached presentation materials from time to time to discuss operations and performance.
- Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act. It is not subject to the liabilities of that section and shall not be incorporated by reference into any other filings.
- Emerging Growth Company: The registrant has indicated it is an emerging growth company.
Investor Verification Checklist
- Verify the content of the "Presentation Materials" (Exhibit 99.1) posted on the Company's website, as this filing only references their existence.
- Confirm the trading status of Common Stock (BIAF) and Warrants (BIAFW) on the Nasdaq Capital Market.
- Note that the information in this 8-K is not "filed" for liability purposes and should be cross-referenced with the actual presentation deck for operational details.